Insights from SCOPE


What Makes Clinical AI Auditable?

September 17, 2026

In our tightly regulated industry, we all understand that an AI-generated answer does not tell you enough on its own. Clinical teams need a clear record of what the system did, what information and system version it used, who reviewed the result, and what happened next.

This becomes especially important when AI supports clinical trial activities such as patient matching, protocol interpretation, data review, risk detection, medical coding, site selection, or document generation. The closer the output comes to participant safety, data reliability, or regulatory decision-making, the stronger the evidence behind its use must be.

Auditability provides that evidence. It allows an organization to explain how an AI-supported process worked at a specific point in time and demonstrate that appropriate controls remained in place.

 

What Makes Clinical AI Auditable?

Clinical AI is auditable when an authorized reviewer can trace the complete path from input to action. That record should show:

  • The intended purpose of the AI system
  • The data or documents it accessed
  • The model, configuration, and instructions used
  • The output it produced
  • Any confidence score, source evidence, or uncertainty presented
  • The person responsible for reviewing the output
  • Whether the recommendation was accepted, changed, or rejected
  • The action taken after review
  • Any subsequent changes to the model or workflow

The required level of detail will vary by use case. An AI tool that summarizes internal meeting notes does not need the same controls as one that helps identify safety signals or assess patient eligibility.

Auditability should therefore be designed around risk, intended use, and the consequences of an incorrect output.

 

Why Is the Final Output Insufficient?

An AI-generated result can look clear and convincing while revealing very little about how it was produced. A reviewer may see a patient match, risk classification, proposed code, or protocol interpretation without knowing whether the system used the correct source data or applied the latest approved configuration.

The same input may also produce a different response after a model, prompt, rule, or knowledge source changes. If the organization preserves only the final output, it may be impossible to reproduce the conditions under which the original recommendation was made.

A reliable audit trail captures the operational context surrounding the result. This gives reviewers enough information to understand what happened without relying on memory, email records, or explanations assembled after the fact.

 

How Does Intended Use Shape the Audit Trail?

Teams should define the AI system’s intended use before deciding what to log and monitor. A broad description such as “support clinical operations” leaves too much room for inconsistent use and unclear accountability.

A useful intended-use statement identifies the task, the user, the expected output, and the role that output plays in the workflow. For example, a patient-matching tool may be approved to prioritize records for coordinator review while remaining outside the final determination of eligibility.

That distinction affects the controls required. If the output only directs attention, the audit trail should show which records were prioritized and how coordinators evaluated them. If the output contributes directly to a regulated decision, the organization may need stronger validation, approval, documentation, and change-control processes.

Clear boundaries also help prevent the tool from gradually being used for decisions it was never evaluated or approved to support.

 

Which Inputs Should Be Traceable?

Auditable AI begins with traceable inputs. Teams should be able to identify the records, datasets, documents, or knowledge sources available to the system when it generated an output.

This does not always require storing additional copies of sensitive data. The audit trail may instead preserve record identifiers, source locations, timestamps, data versions, access details, and links to the controlled systems where the information resides.

Input traceability helps answer practical questions:

  • Did the system use the correct protocol version?
  • Were patient records current at the time of matching?
  • Did the tool have access to all required laboratory results?
  • Was a policy or controlled document missing from the knowledge source?
  • Did a data transformation change the information before analysis?
  • Was the user authorized to access the underlying records?

These questions often matter as much as the performance of the model itself. An AI system can function as designed and still produce an unreliable result when the input is incomplete, outdated, incorrectly mapped, or outside the intended scope.

 

What AI Details Need to Be Recorded?

The audit record should identify the model and supporting components responsible for the output. Depending on the system, this may include:

  • Model name and version
  • Approved configuration
  • System instructions or prompt template
  • Retrieval or knowledge sources
  • Relevant rules or thresholds
  • Date and time of execution
  • User or system that initiated the task
  • Software version and deployment environment

Recording this information allows teams to connect an output with the exact operating conditions present at the time.

This becomes more complicated when organizations use externally hosted models that change over time. Contracts and technical controls should clarify how model updates are communicated, whether previous versions remain available, and what evidence the provider can supply when an output needs to be reviewed.

Organizations should also distinguish between changes to the underlying model and changes to the surrounding workflow. A revised prompt, altered threshold, new data source, or different retrieval method can affect results even when the model itself remains unchanged.

 

Does Auditability Require Explaining Every AI Decision?

An audit trail should show the basis for an output in a form that qualified users can evaluate. That may include cited source passages, relevant patient attributes, triggered rules, supporting records, confidence measures, or clearly identified areas of uncertainty.

Teams do not need a technical description of every internal calculation. They need enough evidence to understand whether the output was grounded in the right information and whether it was reasonable to use within the approved workflow.

The type of explanation should match the task. A patient-matching system might show which eligibility criteria appear satisfied, which remain uncertain, and which source records support the assessment. A document-generation tool might link drafted content to the approved source materials it used.

Useful explanations make review easier. They should help qualified users confirm, question, or reject the output rather than simply encourage acceptance.

 

How Should Human Review Be Documented?

Human oversight becomes meaningful when the workflow records what the reviewer actually did. A generic approval button may confirm that someone opened the result, but it provides little evidence that the output received an appropriate review.

The audit trail should capture the reviewer’s identity, role, decision, and any changes made. When an output is rejected or substantially revised, recording a reason can help the organization identify recurring limitations and improve the system.

The review process should also reflect the significance of the task. A low-risk draft may require a basic accuracy check, while a recommendation related to patient eligibility, safety, or critical data may require review by someone with specific clinical or functional qualifications.

Organizations should define when human approval is required, which roles can provide it, and what happens when reviewers disagree with the AI output. These responsibilities should be part of the workflow design rather than left to individual judgment after deployment.

 

How Should AI Changes Be Controlled?

AI systems rarely remain static. Models, prompts, data sources, rules, interfaces, and integrations may all change after implementation.

Each change should be evaluated according to its potential effect on the approved use case. Minor interface updates may present little risk, while a new model version or revised eligibility prompt may require testing before release.

A practical change-control process should document:

  • What changed and why
  • Which workflows and users may be affected
  • Whether validation or testing is required
  • Who reviewed and approved the change
  • When the change entered production
  • How performance will be monitored afterward
  • Whether rollback is possible

Version history allows teams to connect every output to the correct system configuration. It also helps them determine whether an unexpected pattern began after a specific change.

 

What Should Performance Monitoring Include?

Validation provides evidence that an AI system performs adequately before or during implementation. Ongoing monitoring shows whether that performance continues in real use.

Monitoring should focus on outcomes that matter to the workflow. Depending on the use case, teams may track accuracy, false positives, false negatives, reviewer overrides, processing time, missing citations, screen failures, data discrepancies, or escalation rates.

Patterns across user groups, sites, countries, therapeutic areas, or patient populations may reveal that the tool performs differently in certain settings. Monitoring can also show whether staff are using the system as intended or developing workarounds that weaken oversight.

Organizations need defined thresholds for intervention. When performance declines or unexpected behavior appears, the team should know who investigates, whether use should be limited, and what evidence is needed before the system returns to normal operation.

 

Who Owns Clinical AI Auditability?

Auditability depends on shared work, but ownership must remain clear. Technology teams may manage infrastructure and logging, quality teams may define control requirements, functional experts may validate outputs, and privacy or security teams may oversee data access.

A named business owner should remain accountable for the use case throughout its lifecycle. That owner should understand how the AI fits into the clinical process, which risks require monitoring, and who has authority to approve changes.

Vendor responsibilities should be equally clear. Sponsors, CROs, sites, and technology providers need agreement on which records each party retains, how long they remain available, and how information will be supplied during an audit, inspection, investigation, or quality review.

These questions are easier to resolve before implementation. Once a system is embedded across studies and sites, missing logs or unclear ownership can be difficult to correct.

 

Build the Evidence Into the Workflow

Clinical AI becomes easier to audit when evidence is created as the work occurs. Data sources, system versions, outputs, reviews, changes, and actions should be captured through the normal workflow rather than reconstructed later.

This approach supports more than inspection readiness. It helps teams understand whether the technology is performing as expected, where people are overriding it, and which changes improve or weaken results.

Auditability also supports adoption. People are more likely to rely on an AI system when they can see the evidence behind its outputs, understand their own responsibilities, and know that the organization can examine what happened when questions arise.

As clinical AI moves into more consequential workflows, clear records will become part of responsible implementation. Organizations should be able to explain how an AI-supported decision was reached, who remained accountable, and why the resulting action was appropriate.

 

Continue the Conversation at SCOPE Summit Europe

Clinical AI governance, validation, data integrity, and practical implementation will be important areas of discussion at SCOPE Summit Europe. Leaders from across clinical research will explore how organizations can move AI into real workflows while maintaining oversight, accountability, and confidence in the results.

Learn more and register here.

SCOPE of Things Podcast